Can we use bone turnover markers as targets for antiresorptive treatment in postmenopausal osteoporosis ? an analysis from two phase 3 clinical trials

Conference proceeding

Peer reviewed

J.P. Brown, P. Dakin, P. Hadji, M.R. McCLUNG, P.D. Miller, Jean-Yves Reginster, R.B. Wagman, A. Wang and E. McCLOSKEY

Arthritis and Rheumatology, 67 (S10), 515-517 (2015); 2015 ACR/ARHP Annual Meeting, San Francisco, United States [US], du 6 au 11 novembre 2015

2015

Abstract

General & internal medicine

Human health sciences

Médecine générale & interne

Sciences de la santé humaine

1 Record Views

Title: Can we use bone turnover markers as targets for antiresorptive treatment in postmenopausal osteoporosis ? an analysis from two phase 3 clinical trials
Creators - without role: J.P. Brown
P. Dakin
P. Hadji
M.R. McCLUNG
P.D. Miller
Jean-Yves Reginster
R.B. Wagman
A. Wang
E. McCLOSKEY
Conference: Arthritis and Rheumatology, 67 (S10), 515-517 (2015); 2015 ACR/ARHP Annual Meeting, San Francisco, United States [US], du 6 au 11 novembre 2015
Publisher: Wiley
Identifiers: 9951848908331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding